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Abstract
Background: Asthma is a chronic lung disease that affects more than 23 million people in the United States,
including 7 million children. Asthma is a difficult to manage chronic condition associated with disparities in health
outcomes, poor medical compliance, and high healthcare costs. The research network coordinating this project
includes hospitals, urgent care centers, and outpatient clinics within Carolinas Healthcare System that share a
common electronic medical record and billing system allowing for rapid collection of clinical and demographic
data. This study investigates the impact of three interventions on clinical outcomes for patients with asthma.
Interventions are: an integrated approach to care that incorporates asthma management based on the chronic
care model; a shared decision making intervention for asthma patients in underserved or disadvantaged
populations; and a school based care approach that examines the efficacy of school-based programs to impact
asthma outcomes including effectiveness of linkages between schools and the healthcare providers.
Methods/Design: This study will include 95 Practices, 171 schools, and over 30,000 asthmatic patients. Five groups
(A-E) will be evaluated to determine the effectiveness of three interventions. Group A is the usual care control
group without electronic medical record (EMR). Group B practices are a second control group that has an EMR
with decision support, asthma action plans, and population reports at baseline. A time delay design during year
one converts practices in Group B to group C after receiving the integrated approach to care intervention. Four
practices within Group C will receive the shared decision making intervention (and become group D). Group E will
receive a school based care intervention through case management within the schools. A centralized database will
be created with the goal of facilitating comparative effectiveness research on asthma outcomes specifically for this
study. Patient and community level analysis will include results from patient surveys, focus groups, and asthma
patient density mapping. Community variables such as income and housing density will be mapped for
comparison. Outcomes to be measured are reduced hospitalizations and emergency department visits; improved
adherence to medication; improved quality of life; reduced school absenteeism; improved self-efficacy and
improved school performance.
Discussion: Identifying new mechanisms that improve the delivery of asthma care is an important step towards
advancing patient outcomes, avoiding preventable Emergency Department visits and hospitalizations, while
simultaneously reducing overall healthcare costs.
Keywords: asthma, comparative effectiveness research, shared decision making, integrated approach to care
Background
Significance
Asthma is a chronic lung disease that affects more than
23 million people in the United States, including
approximately 7 million children [1,2] The burden of
asthma in the U.S. is high, accounting annually for 2
million emergency department visits, 504,000 hospitali-
zations, 13.6 million physician office visits, and over
4,200 deaths while resulting in $15 billion in direct
medical costs [3-5]
In North Carolina during 2007, the lifetime prevalence
of asthma in adults was 12.1%, impacting over 800,000
individuals [6] The prevalence of asthma was dispropor-
tionately higher in African American and Native
* Correspondence: Lisa.Hebert@carolinashealthcare.org
2Carolinas Physicians Network, Carolinas HealthCare System, PO Box 32861,
Charlotte, NC 28232, USA
Full list of author information is available at the end of the article
Tapp et al. BMC Health Services Research 2011, 11:188
http://www.biomedcentral.com/1472-6963/11/188
© 2011 Tapp et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.A m e r i c a np o p u l a t i o n sa sw e l la sl o wi n c o m ep o p u l a -
tions [7] Asthma prevalence for the state also reached
17.8% in children under the age of 17 [7] Unfortunately,
n o to n l yi sa s t h m ap r e v a l e n c e increasing in the Caroli-
nas, but many patients suffering with asthma lack ade-
quate control of their symptoms. Indeed, over 50% of
a d u l t sn o t e da s t h m as y m p t o m sm o r et h a no n c ep e r
week and 21% had daily symptoms [7] This resulted in
one-third of adults losing at least one day of work
because of their asthma over the prior 12 months, and
24% of asthma patients having at least one Emergency
Department (ED) or urgent care visit related to their
asthma during this same period of time [7] Rates of ED
utilization for asthma management were also almost
200% higher for minority children than non-minority
children.
Our state’s asthmatic patients also frequently lack a
usual source of care, and 45% of asthmatics went with-
out a visit to their regular physician over the past year
[7] Patients with asthma also report a lower quality of
life, with 18% of all asthmatic patients rating their health
overall as poor [6] Hospitalization rates are also higher
for asthmatic patients and a significant health expense
for the state. Over $88 million was spent on hospitaliza-
tions for asthma in 2004 costing on average $8,259 per
hospital stay.
T h e2 0 0 9I n s t i t u t eo fM e d i c i n e( I O M )r e p o r ti d e n t i -
fied two priorities in the need for comparative effec-
tiveness research on asthma including the need to
study an integrated approach to care and shared deci-
sion making [8] The agency for healthcare quality and
research (AHRQ) has also placed asthma on the prior-
ity list of conditions for comparative effectiveness
research with particular interest in impacting popula-
tions that are low-income, minority groups, women,
children, elderly individuals, and individuals with spe-
cial health care needs, such as those who live in inner-
city and rural areas. This attention to asthma is related
to the burden of the disease on the U.S. population,
disparities on outcomes for asthmatic patients, and the
lack of knowledge of how to improve adherence to
medications and subsequently improve asthma out-
comes [9-17] Gaps in our knowledge of the optimal
medical management and predictors of asthma out-
comes (including environmental triggers) are also pre-
s e n ta n dn e e dt ob ea d d r e s s e db yc o m p a r a t i v e
effectiveness studies [18-24].
Potential solutions include more comprehensive
asthma management strategies that build upon existing
successes in the development of integrated care systems;
special emphasis on targeting high-risk populations; the
use of self-management and shared decision making
approaches to care; and school-based interventions that
can be linked with primary care providers.
The National Asthma Education and Prevention Pro-
gram (NAEPP) asthma guidelines emphasize that the
goal for optimal asthma control is to reduce both
impairment and risk, and recommend a stepwise
approach to pharmacotherapy [25,26]. Measurement of
asthma control can be complex, encompassing physical
examination, objective tests, and patient history [26].
Well-controlled asthma is characterized by: experience
of symptoms and use of a rescue medication twice a
week or less, no early morning or nighttime awakenings,
no limitations on activities of daily living, normal forced
expiratory volume in 1 second (FEV1) or peak expiratory
flow (PEF) test results, and controlled asthma as deter-
mined by physician and patient assessments [27].
Prevention and reduction of asthma exacerbations are
key to reducing risk associated with asthma. NAEPP
guidelines define asthma exacerbation as an “acute or
sub-acute episode of progressively worsening shortness
of breath, cough, wheezing, and chest tightness–or some
combination of these symptoms” [25] Although most
asthma exacerbations are treated in an outpatient set-
ting, they present considerable difficulty for patients,
including increased healthcare utilization, lost work pro-
ductivity, school absences and increased healthcare costs
[28].
One individualized behavioral approach to asthma dis-
ease management is the use of an asthma action plan,
developed through asthma education activities to
increase a patient’s knowledge and skills with regard to
asthma control [25,29-31] The National Institute of
Allergy and Infectious Diseases (NIAID) inner-city
asthma studies program found that a home-based
approach tailored to an individual child’ss p e c i f i cr i s k
factors provided a more effective intervention strategy,
especially with the inclusion of a written asthma action
plan [32,33].
Methods/Design
This study received ethics approval from the Institu-
tional Review Board of Carolinas HealthCare System.
Description of all interventions
This study will include 95 Practices, 171 schools, and
over 30,700 asthmatic patients. The interventions to be
compared will include (Figure 1, Table 1): Group A:
control practices providing usual care; Group B: control
practices with a centralized electronic medical record
(EMR), decision support tools, and population manage-
ment tools; Group C: intervention practices have all the
tools of Group B, but use an integrated system based on
the Chronic Care Model to improve asthma outcomes;
Group D: intervention practices will have all tools avail-
able to Group C with the addition of implementation of
a shared decision making approach to care; and Group
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through school-based nurses and care managers.
Three main interventions are planned:
1) An integrated approach to care (IAC) for asthma
management
Here our objective is to compare the effectiveness of an
integrated approach to asthma management based on
the chronic care model (CCM) with a non-integrated
episodic care model (usual care control). This model
based on the CCM, includes decision support, an elec-
tronic Asthma Action Plan, population management
tools, training in the practice redesign and rapid cycle
process improvement by a quality improvement coach,
and linkages to community resources. This approach
will be compared to control practices (A) and practices
that receive the tools without training with a coach (B).
2) A Shared Decision Making (SDM) approach
The objective is to compare the effectiveness of a com-
bined shared decision making and IAC approach (C)
with the integrated approach alone and with usual care
(control). This model is based on the successful inter-
vention developed by Wilson and colleagues that
Figure 1 Study Design. This study will include 95 Practices, 171 schools, and over 30,700 asthmatic patients. Five groups (A-E) will be evaluated
to determine the effectiveness of each intervention. Group A is the usual care control group. Group B practices will provide a second control
group with an EMR with decision support, Asthma action plans, and Population reports (EAP) at baseline. A time delay design will be used as all
practices in Group B will receive the Integrated Approach to Care (IAC) intervention with 10-12 practices receiving the intervention every 2
months over a 1 year period of time. Four practices within Group C will receive the Shared Decision Making (SDM) approach intervention with 1
practice receiving the intervention every 4 months over a 2 year period. Group E will receive School Based Care (SBC) through case
management within the schools.
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positively impact patient medication compliance and
asthma self-management. This model will be implemen-
ted in select practices that have already implemented
the IAC approach to determine if additional benefit can
be gained using SDM. Practices receiving the SDM
intervention also primarily serve disadvantaged popula-
tions including the uninsured, Medicaid patients, dis-
abled Medicare patients, and minority groups.
3) A School-Based Care (SBC) Approach
Here our objective is to compare the effectiveness of a
school-based approach to care with the integrated
approach to care and with and without the shared deci-
sion making approach to care and against the control.
This intervention will provide an electronic data capture
system to a robust CDC funded school-based interven-
tion to assist with evaluation and to link the school-
based care team with primary care providers. This sys-
tem has identified almost 8,500 asthmatic children who
will be a part of this intervention. Outcomes for chil-
dren will be compared to children in control practices
as well as practices in the IAC and SDM approach.
Clinical Outcomes
The major clinical outcomes goals are: reduced hospita-
lizations and emergency department visits; improved
adherence to medication; improve quality of life;
reduced school absenteeism; improved self-efficacy and
improved school performance. Associated quality goals
are to improve percentage of patients with persistent
asthma who are prescribed a controller medication; and
those with asthma who receive a flu vaccination. Quality
goals will be measured by the percentage of patients
who reach the goal out of all patients identified with the
disease. The three interventions that will be undertaken
each have the potential to impact these goals. The data
collected for the evaluation of the three approaches to
asthma management will also be leveraged to identify
other important variables that impact asthma outcomes
including: pharmaceutical management, co-morbidities
(Tobacco Use/Exposure, GERD, Allergic Rhinitis,
Obesity, Sleep Apnea), patient demographics (age, sex,
race/ethnicity, insurance status), and community level
variables (neighborhood quality of life, build environ-
ment and transportation elements, pollution sources,
and housing density).
Setting
The research network coordinating this project (The
Mecklenburg Area Partnership for Primary Care
Research, MAPPR) includes the hospitals, urgent care
centers, and outpatient clinics within Carolinas Health-
care System (CHS) that share a common Electronic
Medical Record (EMR) and billing system allowing for
rapid collection of clinical and demographic data (Figure
2). This vertically integrated hospital system provides
care to over 1.2 million patients including over 38,000
patients with a diagnosis of asthma. Between 2008 and
2009, these patients were responsible for almost 17,500
hospitalizations and 68,000 clinic visits. The research
network includes a group of ambulatory clinics that
together provide over 85% of care to the uninsured
County Containing CHS Facility
North Carolina
South Carolina
Figure 2 Map of North and South Carolina Showing the Scope
of Carolinas Healthcare System (CHS). Each county shaded in
green is home to a CHS facility including the 32 hospitals and 95
clinics that will take part in this project.
Table 1 Asthmatic Patients Seen in the CHS System 2008
Number of Patients Number of Clinic Visits
Total Number of Unique Patients with an Asthma Diagnosis 38,634 77,582
African American Race 14,168 34,551
Hispanic Ethnicity 2,043 4,596
Age < 18 11,058 21,357
Number within Mecklenburg County 16,458 41,961
Uninsured, Medicaid, or Medicare 13,564 31,022
Number of Hospitalizations for Asthma 10,321 NA
Number Emergency Room Visits 30,121 NA
CHS School Children with Asthma 8,500 NA
Tapp et al. BMC Health Services Research 2011, 11:188
http://www.biomedcentral.com/1472-6963/11/188
Page 4 of 10patients within the surrounding community. Inclusion of
the 92,000 patients who receive care within these clinics
allow the evaluation of the effectiveness of interventions
for asthma management within a large population of
poor and/or underserved community members. The
MAPPR network includes the Mecklenburg County
Health Department and the county school system
(Charlotte Mecklenburg Schools, CMS). Indeed, CHS
employs the 121 school nurses who assist with manage-
ment of children with asthma in the school setting.
Development of the Intervention
The approach is to implement the three separate but
interrelated interventions across the community. The
primary intervention, the integrated approach to asthma
management, has been implemented in 10 practices,
and through this project will be deployed in 65 addi-
tional practices. In addition, an active federally funded
school-based system of care will be enhanced through
this project allowing improved evaluation and compari-
son of outcomes between the school’s system of care
and other intervention as well as allowing the creation
of a school to healthcare provider link.
Database Development
The overall strategy for this study is to create a centra-
lized database for evaluation of comparative effective-
ness of five different groups for management of asthma
patients. The new database will draw information from
the Carolinas Healthcare Systems billing and clinical
databases, Medicaid claims data, school system data,
chart abstraction, community level datasets, patient sur-
veys and focus groups.
A centralized database will be created with the goal of
facilitating comparative effectiveness research on asthma
outcomes specifically for this study. The database
named ACER (Asthma Comparative Effectiveness
Research Database) will be setup using Microsoft SQL
Server 2005 (Redmond, WA) and designed to support
SAS (SAS Institute, Cary, NC) that is the standard ana-
lysis software used within the institution. The data will
flow from 8 different sources including: the healthcare
system’s billing data, the healthcare system’sc l i n i c a l
data, school data from the Institute for Social Capital,
school nurse data, Medicaid claims data, patient level
data (from surveys and focus groups), and community
level data from the Center for Metropolitan Studies
(Figure 3).
Any patient that has had a diagnosis of asthma
recorded for billing purposes at any visit throughout the
system since 2008 will be identified for the study as hav-
ing asthma. This system recorded 38,634 unique
patients for 2008 resulting in 77,582 visits to primary
care practices. The unique medical records for each of
these patients will be identified and the healthcare
utilization patterns for thesep a t i e n t sw i l lb em o n i t o r e d
prospectively through the course of the study. Addi-
tional data elements drawn from this dataset include
patient demographics (age, gender, sex, race/ethnicity,
and insurance type) as well as concurrent diagnoses.
For this study, clinical data from the EMR will be
drawn from 75 of the study clinics (65 clinics in Group
B and 10 clinics in Group C). All patients with asthma
will be identified from billing data and the same unique
medical record number will be used to pull these
patient’s clinical data. Data elements that can be pulled
include: Tobacco Use/Exposure, assessment of daytime/
nighttime symptoms, controller medication for persis-
tent asthma, action plan given/updated and flu vaccine
up to date.
The clinics in this study that are not connected to the
EMR will be used as control practices. Clinical data
from these clinics is abstracted from charts by the CHS
quality team and will be ongoing during the 3 years of
this study for comparison. Data collection will occur on
a quarterly basis and will include: Tobacco Use/Expo-
sure, assessment of daytime/nighttime symptoms, con-
troller medication for persistent asthma, action plan
given/updated, and flu vaccine up to date.
A local not for profit institute has been working with
the Charlotte Mecklenburg School System for the past 4
years to store data for community-wide research. The
Institute stores data on school absenteeism and school
performance including End of Grade testing results. The
school data will be added to the ACER server for the
study to examine changes in school performance and
absenteeism that are related to the study interventions.
The management of children with asthma within the
school system through school-based nurses has enor-
mous potential to improve asthma outcomes. This study
will support the development of an electronic data cap-
ture system for school nurses. Data elements collected
will include clinical measures including peak flows,
asthma medications utilization, and the Asthma Action
Plan.
The North Carolina Medicaid System is one of the
most successful in the country in terms of providing
high quality of care at a low cost [34] This system,
Community Care Partners of North Carolina, works by
incentivizing primary care physicians to provide preven-
tative care through the assistance of case managers [35]
CCPGM and Carolinas Healthcare System have a data
sharing system allowing access to data for the Medicaid
patients with asthma. The data are collected electroni-
cally and includes health services utilization (hospitaliza-
tions, ED and clinic visits) and data on medication
compliance (prescriptions filled). These data are sent to
CHS on a monthly basis and will continue to be shared
for this study. Data for Medicaid will be matched based
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ACER database for analysis.
Patient Level Data
Patient level data will be collected using direct patient
surveys, focus groups, and information exchange during
the community forums.
Surveys
Depending on patient age, the patient survey will include
the Mini Asthma Quality of Life Questionnaire (Mini-
AQLQ) or Mini Pediatric Asthma Quality of Life Ques-
tionnaire (Mini-PAQLQ), the Asthma Therapy Assess-
ment Questionnaire (ATAQ) and 2 additional five-point
scale questions added by the research team. The Mini
AQLQ (5 items) will licensed from QOLteck (West Sus-
sex, UK) and used to collected data from all patients that
are 17 years and older where this survey has been vali-
dated [36] The Mini PAQLQ will also be licensed from
QOLteck, and this 13 question instrument will be used
to assess quality of life in children between the ages of 7
and 17. The 5 point ATAQ questionnaire will be used to
evaluate the effectiveness of asthma management for all
patients. The pediatric version will be administered for
children age 5-17 and adult version for patients age 17
and older [37]. The final questions are identical to those
used by Wilson and colleagues to measure the patient’s
perceptions of a shared decision making approach and
asthma self-efficacy [37-39]T h e s eq u e s t i o n sw i l la s k
about the patients’ perceptions of the quality of care they
received and the influence they had versus the medical
team in the development of their treatment plan. The fin-
ished survey will include 12 questions for adults and 20
questions for children under the age of 17 which will be
printed on a single page for mailing.
Surveys will be mailed to a randomly selected group of
asthma patients who receive care within the 95 clinics
Figure 3 Development of the Asthma Comparative Effectiveness Research Database (ACER).D a t aw i l lb ec o l l e c t e df r o m8s o u r c e si n t o
the database including: Billing data, clinical data drawn electronically from the EMR, School data, Information collected by the school-based
intervention, Medicaid data, clinic data via chart abstraction from control practices without an EMR, Patient level data from surveys and
community-level data from the Center for Metropolitan Studies.
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collecting 100 surveys from each of the 5 groups at each
time point. Patients will be incentivized to complete the
survey with a $10 gift card for participation. Five of the
clinics in this study are part of a network that provides
care to disadvantaged patients including the uninsured,
low-income minority populations, the indigent, disabled
Medicare, and Medicaid patients. These populations
tend to have frequent address changes and lower rates
of literacy, resulting in lower rates of participation with
mailed surveys. This group is of key importance for this
research study and 4 of these 5 clinics have been tar-
geted to receive additional interventions to improve
asthma outcomes. Patients that complete the survey on-
site will be provided with a $10 gift card to reimburse
them for the time required to participate.
All survey data will be added to the ACER database
on a weekly basis. Online survey results will be collected
u s i n gS u r v e yM o n k e y( h t t p : //Surveymonkey.com) and
this data with the patient identifier and date of comple-
tion will be downloaded and transferred into ACER.
Mailed surveys will be compiled by the research team
and manually added to the database. In addition, the
date that the survey was mailed and returned will be
included for surveys returned by mail. If a survey is
completed both online and via the mail, the mailed ver-
sion will be discarded.
Focus Groups
Qualitative data will be collected through focus groups
performed with patients (or their parents for children
u n d e ra g e1 7 )a n dp r o v i d e r sf r o me a c ho ft h e5g r o u p s
throughout the study. Each focus group will have
between 8-10 participants and will occur at baseline and
every 6 months to collect qualitative information about
the study. There will also be a focus group once every
1-3 months to evaluate the process and the monthly
asthma meetings. There will be no recruitment for
these, as the participants will be the regular attendees
from the monthly asthma meetings (i.e. providers, key
personnel from the clinic). A focus group guide for
these sessions has been developed by the research team.
Groups B-E will be asked to provide feedback about
their perceptions of the study and its impact on their
ability to receive or provide high quality asthma care.
Particular interest will be focused in these groups on
soliciting critical feedback about the project to be used
for process improvement. Clinics in Group A will also
be asked to participate, but these groups will be asked
more general questions about their management of
asthma patients and how they hope to improve care for
asthma patients in the future. Focus group data will be
analyzed and provided back to all participating practices
and research team. Data from focus groups will be
indentified only by practice and no individual data from
the focus groups will be collected. Focus group data will
not be added to the centralized ACER database.
Community Level Data
Through MAPPR’s affiliation with the University of
North Carolina at Charlotte, UNCC, and Center for
Metropolitan Studies, geocoded data will be made avail-
able for this study showing: housing density, neighbor-
hood quality of life, pollution sources, transportation
and built environment elements, race/ethnicity, and
household income. These data have been developed by
the center or purchased from Claritas (New York, NY).
We will geocode patient addresses for the ACER data-
base which will allow the research team to examine and
map asthma outcomes compared with other community
level variables. One example of this technique can be
seen in Figure 4, where patients with an asthma diagno-
sis within the clinic system for underserved or disadvan-
taged patients are mapped across Mecklenburg County.
These maps can quickly be compared to other commu-
nity-level data that will be shared by the Center for
Metropolitan Studies.
Analysis
Intervention Effectiveness Analysis
Comparisons between each group (A-E) and within
Group E will be performed by statistical tests of regres-
sion model parameters. Specifically, we will generate a
separate regression model for each of the six clinical
measures and both quality measures (Table 2). Compar-
ison groups will be defined as factors in the model. Pro-
pensity score methods will be used to control for
differences in pharmaceutical management, patient
demographics, co-morbidities, and community level
variables between groups. Since Group E is not indepen-
dent of Groups A-D, we will test for significant interac-
tions between Group E and the other groups. A
secondary analysis of the data will be performed to
examine other important variables that impact asthma
outcomes. This includes pharmaceutical management,
co-morbidities (Tobacco Use/Exposure, GERD, Allergic
Rhinitis, Obesity, Sleep Apnea), patient demographics
(age, sex, race/ethnicity, insurance status), and commu-
nity level variables (neighborhood quality of life, build
environment and transportation elements, pollution
sources, and housing density). In this analysis, we will
build a regression model for each of the 6 clinical out-
comes and use pharmaceutical management, patient
demographics, co-morbidities, and community level
variables as predictors. Regression tree methods will be
used to help understand the potentially complicated
interactions between these predictor variables. In both
the primary and secondary analyses, linear mixed effects
models will be used to account for practice-level effects
within intervention group.
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The basic form of our analysis is that of a follow up
study with three years of analysis. We will construct
measures of service use and costs, by category of service
as well as for all services combined, expressing all these
measures in per-time-period terms for comparability
across groups. This will permit comparison among
groups to identify the effects of the intervention on
health disparities, for example. Each of these dependent
variables (use and cost, by service category) is specific to
a calendar year. Thus the basic unit of analysis is the
person-year of use or cost. We will use regression analy-
sis to estimate the mean difference in outcome variables
between groups, where the groups are identified by a
dummy variable to examine effects of the integrated
approach to asthma management based on the chronic
care model (CCM), while holding constant other factors,
and, in a more detailed analysis, by a set of dummy vari-
ables to examine the effects of the group interventions B
through E, as compared with the control group A
receiving usual care. Interactions between the dummy
variable(s) and dummy variables indicating race/ethni-
city will identify the effect of the CCM on health dispa-
rities. Cost savings to be achieved have the potential to
be substantial, especially for the costs of hospitalization,
Patients per Square Mile
0 - 23
24 - 46
47 - 108
Hospital
Figure 4 Map of Asthma Diagnosis in Mecklenburg County.
Map of Mecklenburg County, NC showing Geographic Information
Systems (GIS) analysis of the 6,800 patients with a primary diagnosis
of asthma seen within the community clinic network over 1 year.
The map shows patient density per square mile.
Table 2 Asthma Related Quality Improvement Goals and Outcome
Variable Measure/Instrument Data Source Frequency
Quality of Life Mini AQLQ, Mini PAQLQ, ATAQ Individual Patient
Surveys and Focus
Groups
6 months
Hospitalization
Rates
Inpatient Admission CHS Hospital Data,
Medicaid Data
Monthly
Acute Care
Utilization
ED/Urgent Care Visits CHS Data, Medicaid
Data
Monthly
Primary Care
Utilization
Primary Care Visits
(Fam. Med, Peds, IM)
CHS Data, Medicaid
Data
Monthly
School
Attendance
Days Missed from School School System (CMS)
Data
6 months
School
Performance
Test Scores End of Grade (EOG)
Test Scores
12 months
Demographics Race/Ethnicity, Gender, Age, Insurance Type, Address CHS System Data Monthly
Income Per capital household income, Home Value Claritas, Census Data,
UNC Urban Institute
Data
6 Months
Housing
Density/Location
Homes per sq. mile Claritas, Census Data,
UNC Urban Institute
Data
6 Months
Other Medical
Conditions
Obesity, Growth Delay, Developmental Delay, Upper Respirator Infections, Allergic Rhinitis,
GERD, Diabetes, COPD, Cancer diagnosis, Hypertension, Congestive Heart Failure
CHS Hospital and
clinical data
Monthly
Clinical Outcome
Measures
FEV1, Peak Flow, BMI, Height, Tobacco Use, Tobacco Exposure, Vaccination Rates CHS Electronic Medical
Record/
Chart Abstraction
Monthly/
Quarterly
Medication
Compliance
Asthma Medications Prescribed, Prescriptions Filled, Refill requests CHS Electronic
Prescribing Database,
Medicaid Data
Monthly
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Page 8 of 10which is a major cost driver. For example, using nation-
ally representative data [40] we found that, among per-
sons ages 19-64, the adjusted rate of preventable
hospitalization for asthma for African American women
w a s2 . 2t i m e sa sg r e a ta st h a tf o rn o n - H i s p a n i cw h i t e
women, while the comparable adjusted difference for
men was 4.2 times as great. In this same age range, the
adjusted rate for women was 2.2 times as great for His-
panics as for non-Hispanics, while among men the rate
was 3.3 times as great for Hispanics.
Differences were much larger among those ages 65
and older, with rates 6 times higher than whites among
men for African Americans, and over 8 times higher for
Hispanics. Thus, even a modest reduction in the dispari-
ties of preventable hospitalization attributable to asthma
affecting African Americans and Hispanics will substan-
tially reduce total costs. Of course, in addition to redu-
cing disparities in preventable hospitalization for African
Americans and Hispanics, the intervention is likely to
reduce preventable hospitalization related to asthma for
all persons in the intervention groups.
Discussion
Identifying new mechanisms that improve the delivery of
asthma care is an important step towards advancing
patient outcomes, avoiding preventable Emergency
Department visits and hospitalizations, while simulta-
neously reducing overall healthcare costs. The wide range
of patient types with asthma (eg. pediatrics vs. adults) as
well as the varying degree of severity of the disease makes
it difficult for a single approach to work universally. In
addition, variation in primary care clinics and providers
makes it challenging to implement new practices and con-
cepts around asthma management such as shared decision
m a k i n g .T oo v e r c o m et h e s el i m i t a t i o n s ,t h i ss t u d yw a s
designed with multiple interventions and two control
groups. Perhaps most importantly, the shared decision
making component of the intervention was designed to be
developed and implemented using participatory methods
to insure broad uptake and dissemination.
Acknowledgements
We would like to gratefully acknowledge Drs John Carew, Cheryl Courtland
and Maria Bonaiuto and the member organizations of the MAPPR network
for their assistance with this work. The project described is funded by Award
Number 1R18HS019946-01 from the Agency for Healthcare Research and
Quality.
Author details
1Department of Family Medicine, Carolinas HealthCare System, 2001 Vail
Avenue, Charlotte, NC 28207. USA.
2Carolinas Physicians Network, Carolinas
HealthCare System, PO Box 32861, Charlotte, NC 28232, USA.
Authors’ contributions
All authors made significant contributions to the conception and design of
this study and read and approved the final manuscript. HT and MD drafted
the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 28 June 2011 Accepted: 16 August 2011
Published: 16 August 2011
References
1. What is asthma?. [http://www.nhlbi.nih.gov/health/dci/Diseases/Asthma/
Asthma_WhatIs.html].
2. Current asthma population estimates–in thousands by age, United
States: National Health Interview Survey. 2008 [http://www.cdc.gov/
asthma/nhis/08/table3-1.htm].
3. Moorman J, Rudd R, Johnson C, King M, Minor P, Bailey C, Scalia M,
Akinbami L: National surveillance for asthma–United States, 1980-2004.
MMWR Surveill Summ 2007, 56:1-54.
4. Trends in asthma morbidity and mortality. [http://www.lungusa.org/
finding-cures/our-research/trend-reports/asthma-trend-report.pdf].
5. Skrepnek G, Skrepnek S: Epidemiology, clinical and economic burden, and
natural history of chronic obstructive pulmonary disease and asthma.
Am J Manag Care 2004, 10:S129-S138.
6. Behavioral Risk Factor Surveillance Survey (BRFSS). [http://www.cdc.gov/
brfss/index.htm].
7. Jensen K: The Burden of Asthma in North Carolina, 2006. Book The Burden
of Asthma in North Carolina, 2006 City: NC Division of Public Health; 2006,
(Editor ed.^eds.).
8. Sox HC, Greenfield S: Comparative effectiveness research: a report from
the Institute of Medicine. Ann Intern Med 2009, 151:203-205.
9. Gillissen A: Patients’ adherence in asthma. J Physiol Pharmacol 2007,
58:205-222.
10. National Asthma Education and Prevention Program. Expert panel
report-3: guidelines for the diagnosis and management of asthma. .
11. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interventions for
enhancing medication adherence. Cochrane Database Syst Rev 2008,
CD000011.
12. Bosley CM, Parry DT, Cochrane GM: Patient compliance with inhaled
medication: does combining beta-agonists with corticosteroids improve
compliance? Eur Respir J 1994, 7:504-509.
13. Sackett D, Snow J: The magnitude of compliance and non-compliance
Baltimore: Johns Hopkins University Press; 1979.
14. Gong H, Simmons MS, Clark VA, Tashkin DP: Metered-dose inhaler usage
in subjects with asthma: comparison of Nebulizer Chronolog and daily
diary recordings. J Allergy Clin Immunol 1988, 82:5-10.
15. Coutts JA, Gibson NA, Paton JY: Measuring compliance with inhaled
medication in asthma. Arch Dis Child 1992, 67:332-333.
16. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C:
Noncompliance and treatment failure in children with asthma. J Allergy
Clin Immunol 1996, 98:1051-1057.
17. Gamble J, Stevenson M, McClean E, Heaney LG: The prevalence of
nonadherence in difficult asthma. Am J Respir Crit Care Med 2009,
180:817-822.
18. Cates CJ, Lasserson TJ: Regular treatment with formoterol and an inhaled
corticosteroid versus regular treatment with salmeterol and an inhaled
corticosteroid for chronic asthma: serious adverse events. Cochrane
Database Syst Rev 2010, CD007694.
19. Cates CJ, Lasserson TJ: Combination formoterol and inhaled steroid
versus beta2-agonist as relief medication for chronic asthma in adults
and children. Cochrane Database Syst Rev 2009, CD007085.
20. Ducharme FM, Lasserson TJ, Cates CJ: Long-acting beta2-agonists versus
anti-leukotrienes as add-on therapy to inhaled corticosteroids for
chronic asthma. Cochrane Database Syst Rev 2006, CD003137.
21. Cates CJ, Jefferson TO, Rowe BH: Vaccines for preventing influenza in
people with asthma. Cochrane Database Syst Rev 2008, CD000364.
22. Castro-Rodriguez JA, Rodrigo GJ: The role of inhaled corticosteriods and
montelukast in children with mild-moderate asthma: results of a
systematic review with meta-analysis. Arch Dis Child 2009.
23. Rodrigo GJ, Moral VP, Marcos LG, Castro-Rodriguez JA: Safety of regular
use of long-acting beta agonists as monotherapy or added to inhaled
corticosteroids in asthma. A systematic review. Pulm Pharmacol Ther
2009, 22:9-19.
Tapp et al. BMC Health Services Research 2011, 11:188
http://www.biomedcentral.com/1472-6963/11/188
Page 9 of 1024. Rodrigo GJ, Castro-Rodriguez JA: Anticholinergics in the treatment of
children and adults with acute asthma: a systematic review with meta-
analysis. Thorax 2005, 60:740-746.
25. National Heart Lung and Blood Institute: National Asthma Education and
Prevention Program, Expert panel report 3: Guidelines for the diagnosis
and management of asthma. Book National Asthma Education and
Prevention Program, Expert panel report 3: Guidelines for the diagnosis and
management of asthma City: National Asthma Education and Prevention
Program (NAEPP) Coordinating Committee; 2007, (Editor ed.^eds.).
26. Navarro R, Rice G, Schaecher K: Asthma management guidelines: updates,
advances, and new options. J Manag Care Pharm 2007, 13:S3-S11.
27. Joint Task Force on Practice Parameters, American Academy of Allergy,
Asthma and Immunology, American College of Allergy, Asthma and
Immunology and Joint Council of Allergy, Asthma and Immunology:
Attaining optimal asthma control: a practice parameter. J Allergy Clin
Immunol 2005, 116:S3-S11.
28. Chronic care for low-income children with asthma: strategies for
improvement. Research in Action Issue 18. AHRQ Publication No. 05-
0073. [http://www.ahrq.gov/research/chasthria/chasthria.htm].
29. Kolbe J: Asthma education, action plans, psychosocial issues and
adherence. Can Respir J 1999, 6:273-280.
30. Rank M, Volcheck G, Li J, Patel A, Lim K: Formulating an effective and
efficient written asthma action plan. Mayo Clin Proc 2008, 83:1263-1270.
31. Gibson P, Powell H: Written action plans for asthma: an evidence-based
review of the key components. Thorax 2004, 59:94-99.
32. Mayberry RM, Daniels P, Akintobi TH, Yancey EM, Berry J, Clark N:
Community-based organizations’ capacity to plan, implement, and
evaluate success. J Community Health 2008, 33:285-292.
33. Morgan D: Focus groups. Annual Review of Sociology 1996, 22:129-152.
34. Wegner SE, Dobson LA, Lawrence WW, Ciesco E: Role and structure of the
North Carolina Physician Advisory Group: a collaborative effort between
providers and Medicaid. North Carolina medical journal 2009, 70:270-273.
35. St Martin E, Harris-Stevens L: One size does not fit all: tailoring case
management to a community. North Carolina medical journal 2009,
70:241-244.
36. Olajos-Clow J, Minard J, Szpiro K, Juniper EF, Turcotte S, Jiang X, Jenkins B,
Lougheed MD: Validation of an electronic version of the Mini Asthma
Quality of Life Questionnaire. Respir Med 2010.
37. Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, Vollmer WM:
Shared Treatment Decision Making Improves Adherence and Outcomes
in Poorly Controlled Asthma. Am J Respir Crit Care Med 2010, 181:566-577.
38. Schlosser M, Havermans G: A self-efficacy scale for children and
adolescents with asthma: construction and validation. J Asthma 1992,
29:99-108.
39. Tobin DL, Wigal JK, Winder JA, Holroyd KA, Creer TL: The “Asthma Self-
Efficacy Scale”. Ann Allergy 1987, 59:273-277.
40. Laditka JN, Laditka SB: Race, ethnicity and hospitalization for six chronic
ambulatory care sensitive conditions in the USA. Ethn Health 2006,
11:247-263.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6963/11/188/prepub
doi:10.1186/1472-6963-11-188
Cite this article as: Tapp et al.: Comparative effectiveness of asthma
interventions within a practice based research network. BMC Health
Services Research 2011 11:188.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tapp et al. BMC Health Services Research 2011, 11:188
http://www.biomedcentral.com/1472-6963/11/188
Page 10 of 10